Business
PAOG To Build Pharmaceutical Hemp Cultivar Facility On PURA Farmersville Site
PAOG To Build Pharmaceutical Hemp Cultivar Facility On PURA Farmersville Site.
About this update from Pao Group, Inc.
[{"type":"text","content":"\n\n\n\nPAOG To Build Pharmaceutical Hemp Cultivar Facility On PURA Farmersville Site\n\n/* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n\n\n\n\n\n\nPAOG To Build Pharmaceutical Hemp Cultivar Facility On PURA Farmersville Site\nPR Newswire\nSANDUSKY, Ohio, Sept. 16, 2020\n\n\n\nSANDUSKY, Ohio, Sept. 16, 2020 /PRNewswire/ -- PAO Group, Inc. (USOTC: PAOG) today announced an agreement with Puration, Inc. (USOTC: PURA) to build a proprietary hemp cultivar development facility on PURA's Farmersville, Texas branded site.  \nPAOG recently acquired a hemp cultivation business from PURA and is now expanding upon that business to develop a proprietary hemp cultivar in conjunction with the company's overall pharmaceutical focus.\nPAOG is developing a hemp derived cannabidiol (CBD) pharmaceutical treatment for Chronic Obstructive Pulmonary Disease (COPD).\nThe COPD treatment, RespRx, is derived from a patented cannabis extraction method - U.S. Patent No. 9,199,960 entitled \"METHOD AND APPARATUS FOR PROCESSING HERBACEOUS PLANT MATERIALS INCLUDING THE CANNABIS PLANT.\"  \nIn an initial scientific evaluation as a treatment for COPD, RespRx has demonstrated effecting significant increases in respiration rate, tidal volume and inspiratory air flow rate. Overall data from the evaluation demonstrated that RespRx can significantly improve inspiratory lung functions in instances of moderate pulmonary fibrosis. \nPAOG's Farmersville cultivar development operation will include a lab and an environmentally controlled indoor growing facility.  PAOG is working with current cultivars to evolve and produce an ideal plant with full spectrum, high CBD yields to support ongoing RespRx development and to support future CBD pharmaceutical developments.\nPAOG is exploring opportunities to engage with university research in partnership with its hemp cultivar development initiative.\nPURA recently announced a year long initiative to transition PURA from a CBD sports beverage manufacturer into a hemp conglomerate built on lifestyle brand with a broad CBD consumer products reach, and a leading industri...